Atlas Trials

Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions

Clinical trial NCT01903122 · COMPLETED

Trial details

NCT number
NCT01903122
Sponsor
Roxane Laboratories
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Dry Mouth
Start date
2009-02-01
Primary completion
2009-02-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.